Coordinated Action on HIV Clinical Research (CA44)
Last updated on 07 October 2024
In brief
The Coordinated Action ‘HIV Clinical Research’ (CA44) adopts a multidisciplinary, person-centred approach to focus on a wide range of HIV research in France and internationally.
This Coordinated Action promotes patient-centred scientific research with a focus on personalised medicine. Its founding principles combine:
- the promotion of young researchers, particularly in low- and middle-income countries (LMICs),
- close collaboration between Europe and LMICs
- cross-cutting groups, in particular with CA41 ‘Host-virus interactions: basic and translational HIV research’ and CA53 ‘Sexually Transmitted Infections’,
- a translational approach.
Activities
The Coordinated Action helps to determine research priorities. It provides scientific facilitation and networking for researchers, and encourages the emergence of promising projects using a bottom-up or top-down approach. These projects will be submitted to national and international calls for proposals, including those of ANRS MIE.
Workgroups
It is structured into two workgroups to cover the current research priorities of people living with HIV:
- Antiretroviral strategies and co-morbidities
- Immunotherapy (in partnership with the Coordinated Action on Host-Virus Interactions: basic and translational HIV research)
Chair and Co-Chair
Alain Makinson
Montpellier University Hospital
Maxime Hentzien
Reims University Hospital
Serge Éholié
Treichville University Hospital, Côte d’Ivoire
Co-Chair CA44 workgroup on Antiretroviral strategies and co-morbidities
Clotilde Allavena (Nantes Hôtel Dieu University Hospital)
Roland Landman (Bichat Hospital)
Chair CA44 workgroup on Immunotherapy (CA44/CA41)
Pierre Delobel (Toulouse University Hospital)